Medical Robots Market Size

The global medical robots market size was valued at USD 12.8 billion in 2024 and is estimated to grow at 16.6% CAGR from 2025 to 2034. The growing demand for automation in healthcare facilities, coupled with government and private sector investments, as well as the increasing demand for minimally invasive surgery, are among the key factors fueling market growth.

Rising healthcare costs are driving providers to adopt technologies that enhance efficiency and reduce patient care costs. Medical robots can perform certain tasks autonomously, reduce human errors, and optimize resource utilization, making them a cost-effective solution. Additionally, these robots improve precision in surgeries, offer consistent care in rehabilitation, and enhance patient monitoring, leading to better patient outcomes and satisfaction.

Moreover, substantial investments in healthcare robotics research and development from governments, private investors, and technology companies are accelerating innovation and adoption. Grants, subsidies, and partnerships are supporting advancements in robotics applications across healthcare sectors. For example, in January 2024, the Technical University of Munich (TUM) received funding support from The Bavarian Research Foundation for its ForNeRo research project, which focuses on integrating various systems in surgery and imaging into regular surgical procedures.

Medical robots are advanced machines designed to assist in healthcare tasks, ranging from surgery and rehabilitation to diagnostics and patient monitoring. There are various types of medical robots used throughout the industry, including surgical robots, rehabilitation robots, and pharmaceutical robots, among others.

Medical Robots Market Trends

Advances in artificial intelligence (AI), machine learning, 3D imaging, and robotic systems have led to the development of more sophisticated, responsive, and adaptable robots.

• High-resolution imaging, 3D visualization, and real-time navigation systems enable medical robots to operate in intricate environments with greater precision. This is especially beneficial for complex surgeries, as doctors can achieve enhanced visualization of the surgical area, reducing risks and improving patient outcomes.
  
• In addition, technological improvements have significantly lowered production costs for robotic systems, making them more affordable for healthcare providers. The introduction of more cost-effective and modular robots has expanded accessibility, allowing a broader range of healthcare facilities—including smaller hospitals and specialized clinics—to benefit from these solutions.
  
• Furthermore, ongoing technological innovations are driving the miniaturization of robotic components, resulting in smaller, more agile robots. This enables robots to perform tasks in confined spaces, such as within the human body, with minimal disruption to surrounding tissues. These advancements make robotics applicable to microsurgery, endoscopy, and other precision-intensive fields.
  

Medical Robots Market Analysis

Based on product type, the market is segmented into surgical robots, pharmacy and hospital automation robots, rehabilitation robots, telemedicine robots, and non-invasive radiosurgery robots. In 2024, the surgical robots segment dominated the market and generated a revenue of USD 8.1 billion.

• Surgical robots play a crucial role in minimally invasive procedures, where precision and control are essential. These robots enable smaller incisions, reduced blood loss, less postoperative pain, and shorter recovery times. As a result, there is a growing demand from both patients and healthcare providers for faster, safer procedures that deliver better outcomes.
  
• Moreover, hospitals and healthcare providers are increasingly recognizing the competitive advantages of robotic surgery, such as improved patient outcomes, higher patient satisfaction, and the ability to attract more patients seeking advanced care. This demand is further driven by the availability of government grants and private funding to support the adoption of robotic technology.
  

Based on application, the medical robots market is segmented into laparoscopic, orthopedic, neurology, cardiology, pharmacy applications, physical rehabilitation, and other applications. In 2024, the laparoscopic segment is expected to lead the market, generating a significant revenue of USD 4.3 billion.

• Robotic-assisted laparoscopic systems are becoming more sophisticated, with enhanced imaging, 3D visualization, AI-based guidance, and real-time data analytics. These advancements are enabling surgeons to perform complex laparoscopic surgeries with greater precision and minimal trauma to surrounding tissues, thereby fueling demand.
  
• Furthermore, as more surgeons are trained in robotic-assisted laparoscopic techniques, the accessibility of these procedures is increasing. Many medical institutions now offer robotic surgery training, which is broadening the adoption of robotic laparoscopy across specialties and healthcare facilities.
  

Based on end use, the medical robots market is divided into hospitals, ambulatory surgical centers (ASCs), rehabilitation centers, and other end users. The hospitals segment dominated the market in 2024, accounting for a share of 67.2%.

• Hospitals are increasingly adopting robotic-assisted laparoscopic procedures to enhance surgical outcomes. These systems enable surgeons to perform highly precise operations with minimal trauma, leading to fewer complications, reduced infection risks, and faster patient recovery. This focus on improving patient outcomes is a key driver of demand in hospitals.
  
• Additionally, patient preference for minimally invasive procedures is prompting hospitals to offer more robotic-assisted laparoscopic surgeries. Minimally invasive surgeries are associated with reduced postoperative pain, faster recovery, and an improved quality of life. In response to this demand, hospitals are integrating robotic technology to perform complex laparoscopic surgeries that appeal to a broader patient base.
  

The North America medical robots market accounted for majority revenue share and generated a revenue of USD 7.8 billion in 2024. This high revenue share is mainly attributed to significant healthcare expenditure, supportive government initiatives, and rising awareness of diseases.

• Chronic diseases such as obesity, cardiovascular diseases, and gastrointestinal disorders are on the rise in North America, driving the demand for surgeries like bariatric surgery, colorectal surgeries, and gallbladder removals. Laparoscopic procedures, often assisted by robotics, are particularly beneficial for treating these conditions. As a result, hospitals are increasingly adopting robotic-assisted laparoscopic technologies to manage the growing volume of surgeries required to treat these diseases.
  
• Additionally, North America boasts numerous world-class training programs for robotic surgery, leading to a growing number of skilled surgeons trained in robotic-assisted laparoscopic techniques. As more surgeons are trained, hospitals in the region are better equipped to adopt robotic systems. The availability of educational resources and support further drives demand within North American healthcare facilities.
  

The UK is poised for substantial growth in the global medical robots market.

• The UK's National Health Service (NHS) plays a central role in driving the demand for robotic-assisted laparoscopic surgeries. The NHS has been increasingly integrating robotic systems across various hospitals, recognizing the advantages of these technologies in enhancing precision during surgery, reducing recovery times, and improving patient outcomes.
  
• Additionally, as in other developed regions, the UK is witnessing a rise in chronic conditions such as obesity, diabetes, and cardiovascular diseases, which often require surgical intervention. Laparoscopic procedures, assisted by robotic systems, are particularly advantageous for treating these conditions, as they are less invasive and offer faster recovery times.
  

Japan is set to experience notable growth in its medical robots market during the forecast period.

• Hospitals and medical institutions in Japan are early adopters of robotic-assisted laparoscopic technologies, recognizing the significant benefits of robotic surgery in terms of precision, minimally invasive procedures, and faster recovery times. This infrastructure supports the increasing demand for robotic-assisted laparoscopic procedures across the country.
  
• Furthermore, the Japanese government has been supportive of technological advancements in healthcare. Policies that encourage the use of medical technologies, including robotic systems, are helping to drive their integration into hospitals and clinics nationwide.
  

Medical Robots Market Share

Key industry players in the medical robotics market are focusing on technological innovation, including AI integration and enhanced visual systems to improve surgical precision and outcomes. They are expanding robotic platforms across various specialties, such as orthopaedics, urology, and cardiothoracic surgery, to increase versatility. Companies are also emphasizing affordability through cost-effective solutions, financing models, and reduced maintenance costs. Partnerships, acquisitions, and training programs are vital for increasing adoption and expertise. Geographical expansion into emerging markets and the integration of robotic systems with existing hospital technologies are also key priorities.

Medical Robots Market Companies

Prominent players operating in the medical robots industry include:

• ACCURAY
• Aethon
• ARxIUM
• Capsa Healthcare
• Globus Medical
• Hocoma
• Intuitive Surgical
• Johnson & Johnson
• Medtronic
• Omnicell
• Reinshaw
• Smith & Nephew
• Stryker Corporation
• THINK Surgical
• Zimmer Biomet
  

Medical Robots Industry News:

• In February 2022, Smith & Nephew plc announced the launch of the CORI Surgical System in Japan. This system incorporates 3D intraoperative imaging and an advanced robotic precision milling tool, enhancing the surgeon’s ability to measure, plan, and perform knee surgery. The product launch helped the company expand its geographical presence and increase business revenue.
  
• In October 2021, Medtronic plc announced that it had received CE regulatory approval for the Hugo RAS system. This system is designed to address barriers to robotic surgery adoption and is used in urologic surgical procedures, including radical prostatectomy, radical cystectomy, and nephrectomy (partial or radical). This regulatory approval helped the company enhance its customer base, increase its geographic presence, and generate business revenue.
  

The medical robots market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Surgical robots
• Pharmacy and hospital automation robots
• Rehabilitation robots
• Telemedicine robots
• Non-invasive radiosurgery robots

Market, By Application

• Laparoscopic
• Orthopedic
• Neurology
• Cardiology
• Pharmacy applications
• Physical rehabilitation
• Other applications

Market, By End Use

• Hospitals
• Ambulatory surgical centers (ASCs)
• Rehabilitation centers
• Other end users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE